Abstract

We studied the antimicrobial characteristics of cerium oxide (CeO2) nanoparticles synthesized by hydrothermal technique. The versatile characterization techniques were employed to study the CeO2 nanoparticle structural and optical properties. These techniques included field emission scanning electron microscopy, Raman spectroscopy, X-ray diffraction, and transmission electron microscopy. The X-ray diffraction and Raman studies validated the cubic structure of the synthesized CeO2 nanoparticles with average diameters ~3–5 nm. The antibacterial activities and minimal inhibition concentrations (MICs) of CeO2 nanoparticles were tested against ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter sp.). Our data revealed that CeO2 nanoparticles at a concentration of 50 µg/mL generated a maximum inhibition zone against all tested pathogens. However, S. aureus, P. aeruginosa, and K. pneumoniae exhibited the higher sensitivity, while E. cloacae, E. faecium, and A. baumannii were the least sensitive to CeO2 nanoparticles. In conclusion, our results demonstrate that CeO2 nanoparticles possess an effective antibacterial activity against ESKAPE pathogens and may be used as a potential bionanomaterial for in vivo therapeutic applications.

Highlights

  • The progress and spread of drug-resistant microorganisms, as well as their transmissible infections, has become a global challenge [1,2,3]

  • Reports have demonstrated that the antimicrobial-resistance (AMR) abilities of these pathogens severely aggravate the ailments of patients hospitalized for chronic diseases, such as cardiovascular diseases, chronic lung infections, diabetes mellitus, arteriosclerosis, chronic obstructive pulmonary disease (COPD), and cancers [11]

  • The CeO2 nanoparticles were synthesized by hydrothermal process at a temperature

Read more

Summary

Introduction

The progress and spread of drug-resistant microorganisms, as well as their transmissible infections, has become a global challenge [1,2,3]. Reports have demonstrated that the antimicrobial-resistance (AMR) abilities of these pathogens severely aggravate the ailments of patients hospitalized for chronic diseases, such as cardiovascular diseases, chronic lung infections, diabetes mellitus, arteriosclerosis, chronic obstructive pulmonary disease (COPD), and cancers [11]. These patients may be susceptible to the development of wounds due to the presence of a number of bacterial species forming biofilm and many such chronic wounds are difficult to heal, despite aggressive treatment

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call